<DOC>
	<DOCNO>NCT02778321</DOCNO>
	<brief_summary>Cerebral infarction ( CI ) link atherosclerosis large vessel , occlusion small vessel intracerebral ( gap ) , cardioembolic disease rare cause . However , 40 % CI remain unexplained thorough diagnostic workup . They call cryptogenic IC . Atrial fibrillation ( AF ) cause 25 % CI recognize episode paroxysmal AF , asymptomatic unnoticed , may responsible portion IC cryptogenic pace . Recognition episodes great importance since risk embolic FA continue [ 1 , 2 ] motivate anticoagulant therapy startup . Several record technique heart rate evaluate IC detect AF . Their profitability increase duration recording : 3 % typical 24-hour Holter , AF detection rate increase 6 % 7-day surveillance period , 12-23 % 30 day 17-26 % implantable recorder long . Otherwise brief rhythmic heart abnormality detect wan CI without significance episode know . Investigators decide conduct study prospective study good quality sufficient number patient evaluated interest non-invasive record long duration . The randomized CRYSTAL AF use invasive subcutaneous implantable monitor ( Reveal XT ) . To clarify significance arrhythmias presence several cause common 65 , investigator propose record patient hospitalize HF .</brief_summary>
	<brief_title>Prospective Study Evaluating Interest Long-term Cardiac Recording Cerebral Infarction</brief_title>
	<detailed_description>Main objective / secondary The objective study assess prevalence AF patient hospitalize IC detect describe heart rhythmic abnormality report immediately wan IC cryptogenic ( ie without cause without obvious cause ) non-invasive cardiac monitoring . 1 . The primary endpoint : number patient find AF 2 . Secondary Endpoints : typical patient subgroup discover AF rhythm abnormality ; Description population prescribe anticoagulation follow SpiderFlash® recording , cardiac ultrasound parameter ( include surface leave atrium index function mitral annulus ) rhythmic anomaly group atheromatous cryptogenic stroke . Inclusion / non inclusion Inclusion criterion - Patients 65 year , hospitalize cerebral infarction ICU Neurovascular - No history atrial fibrillation flutter - No hypercoagulable - Patient unopposed capable carry 21-day monitoring Exclusion criterion - Patients severe cognitive impairment keep SpiderFlash® 21 day - Previous history AF flutter - Significant artery stenosis require specific treatment ( endarterectomy stenting ) - FA arrival ICU Neurovascular - Trucks pacemaker cardiac defibrillator - Deadline IC 10 day - Other source cardiac embolism - Pejorative prognosis ( mRS≥5 ) The IC define central focal neurological deficit sudden onset confirm CT scan MRI . The minimum workup include ECG monitor continuous cardiac monitoring , transthoracic echocardiography ( transesophageal +/- ) Doppler ultrasound supra-aortic trunk transcranial . Methodology : This interventional study routine care , prospective , single-center , blinded heart rhythm specialist . Investigators use SpiderFlash® , Holter monitor ( technology `` Secure Data '' ) storage capacity enable registration 30 day sufficient autonomy . The SpiderFlash® currently register GHPSJ use various direction include cryptogenic cerebral infarction . The data collect ( see Annex 2 CRF ) : - Demographic data : age , sex , vascular risk factor , antithrombotic therapy entrance , history Transient Ischemic Accident ( TIA ) CI - Data IC : arterial territory , side ( right / leave ) insular cortex reach severity ( NIHSS score ) make examination , echocardiography result , become hospitalization ( mRS ) - Monitoring Results scope ICU Neurovascular . - Presence palpitation - Treatment influence rate ( beta-blockers antiarrhythmic ) - Data cardiac monitoring : time , duration , number detect event A questionnaire evaluate safety SpiderFlash® give patient ( Appendix 3 ) result Holter communicate end recording ( show Circular ) . During screen period one month , 33 eligible patient 65 admit CI 17 patient ( 51 % ) identify include 9 cryptogenic CI 8 either non-significant atheroma rhythm disorder ( ESSV atrial hyperexcitability ) . Among 16 ineligible patient , 4 severe dementia , 11 previous FA 1 significant extracranial stenosis . The patient recruitment period one year one year two-year inclusion period recruit 200 patient originally plan study ( first year inclusion allow u include 73 patient ) The data enter manually paper CRF Excel anonymized include patient identifier ( name IPP ) . The originality study : - Prospective study - Inclusion CI cryptogenic non cryptogenic - Laying SpiderFlash® early CI - Correlation cardiac ultrasound parameter - Analysis blind rhythm specialist ( aware patient characteristic ) - Changing event record ( passage FA ) - Questionnaire `` comfort '' give patient Investigators specify data comfort patient questionnaire transfer company Sorin ; questionnaire meet strict medical interest ( include estimate patient 's ability carry equipment full period ) . Ethics / Regulatory : The data processing carry locally GHPSJ anonymized way . The inclusion patient occur patient information collection non-opposition trace medical record ( Appendix 1 ) . The data enter vascular neurologist anonymously . All patient information remain confidential . partnership : The Sorin company , manufacturer SpiderFlash® provide ( loan ) material sufficient quantity duration study . The GHPSJ : neurologist time CRA The SELARL rythmo : time heart rhythm specialist</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>ICU Neurovascular hospitalize cerebral infarction CI No history atrial fibrillation flutter No hypercoagulable Patient unopposed capable carry 21day monitoring Patients severe cognitive impairment keep SpiderFlash® 21 day Previous history AF flutter Significant artery stenosis require specific treatment ( endarterectomy stenting ) FA arrival ICU Neurovascular Trucks pacemaker cardiac defibrillator Deadline CI 10 day Other source cardiac embolism Pejorative prognosis ( mRS≥5 )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>